Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 25, 2017

View Archived Issues

Brickell Biotech reports results of confirmatory phase IIb study of sofpironium bromide

FDA orphan drug status granted to Synlogic's SYNB-1618

FDA awards orphan drug status to Zealand Pharma's glepaglutide

Momelotinib does not appear to add to erlotinib benefit in NSCLC trial

Catalyst Biosciences and Mosaic Biosciences to develop anti-C3 protease compounds

New candidate prodrug TransCon CNP for treating achondroplasia shows promise

Novel PET tracer 68Ga-NOTA-3PTATE-RGD shows promise for imaging lung cancer, neuroendocrine tumors

Alector and AbbVie enter global collaboration to advance novel immune-neurology candidates

Pain Therapeutics completes phase I study of Alzheimer's candidate

Imprimis Pharmaceuticals launches subsidiary

Safety and immunological data presented for TG-1050 for HBV infection

Minneamrita commences phase I testing of oral minnelide in advanced cancer

Novartis reflects on key milestones of third quarter 2017

Bispecific antibody ALG.APV-527 targets tumor antigen 5T4

MJFF and Tau Consortium fund development of novel PET imaging tracers for neurodegenerative diseases

RespiVert and Topivert Pharma patent kinase inhibitors

Pfizer's glasdegib given orphan drug designation for MDS

Ruzasvir/uprifosbuvir combination highly effective in genotypes 1, 2 and 4 HCV infection

Pulmocide divulges novel RSV fusion inhibitors

Alzheon's ALZ-801 awarded fast track designation from FDA

Collaboration to support Amylyx Pharmaceuticals's phase II study of AMX-0035

Immunocore presents constructs for treating HIV infection and AIDS

FDA grants fast track designation to MIV-711 for treatment of osteoarthritis

TVGV-HB vaccine shows promise in HBV mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...